Physician profile
James G Scanlan
NPI 1962499087
$888.74
in general payments reported to CMS, 2019-2025
15 companies · $331 in 2025
The $331 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $12.27 · 2021: $125 · 2024: $291 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $206.01 | 2024-2025 | Onyx Frontier, Corevalve Evolut R |
| Atricure, INC. | $151.65 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System |
| Esperion Therapeutics, INC. | $144.82 | 2021-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.85 | 2019-2025 | Jardiance |
| Heartflow, INC. | $66.21 | 2024 | |
| Amgen INC. | $49.04 | 2019-2025 | Repatha |
| Celgene Corporation | $40.92 | 2024 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $30.44 | 2020-2025 | Farxiga |
| Bridgebio Pharma, INC. | $23.21 | 2025 | Attruby |
| E.R. Squibb & Sons, L.L.C. | $21.69 | 2025 | Camzyos |
| Sanofi-Aventis U.S. LLC | $18.23 | 2019 | |
| Edwards Lifesciences Corporation | $15.94 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.79 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.19 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $6.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Scanlan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.